These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 11181354

  • 1. Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities.
    Smee DF, Huffman JH, Morrison AC, Barnard DL, Sidwell RW.
    Antimicrob Agents Chemother; 2001 Mar; 45(3):743-8. PubMed ID: 11181354
    [Abstract] [Full Text] [Related]

  • 2. In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.
    Sidwell RW, Smee DF, Huffman JH, Barnard DL, Bailey KW, Morrey JD, Babu YS.
    Antimicrob Agents Chemother; 2001 Mar; 45(3):749-57. PubMed ID: 11181355
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.
    Gubareva LV, Webster RG, Hayden FG.
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3403-8. PubMed ID: 11709315
    [Abstract] [Full Text] [Related]

  • 4. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.
    Govorkova EA, Leneva IA, Goloubeva OG, Bush K, Webster RG.
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2723-32. PubMed ID: 11557461
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.
    Bantia S, Parker CD, Ananth SL, Horn LL, Andries K, Chand P, Kotian PL, Dehghani A, El-Kattan Y, Lin T, Hutchison TL, Montgomery JA, Kellog DL, Babu YS.
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1162-7. PubMed ID: 11257030
    [Abstract] [Full Text] [Related]

  • 6. Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.
    Smee DF, Sidwell RW, Morrison AC, Bailey KW, Baum EZ, Ly L, Wagaman PC.
    Antiviral Res; 2001 Dec; 52(3):251-9. PubMed ID: 11675142
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors.
    Boivin G, Goyette N.
    Antiviral Res; 2002 Jun; 54(3):143-7. PubMed ID: 12062387
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
    Sidwell RW, Huffman JH, Barnard DL, Bailey KW, Wong MH, Morrison A, Syndergaard T, Kim CU.
    Antiviral Res; 1998 Feb; 37(2):107-20. PubMed ID: 9588843
    [Abstract] [Full Text] [Related]

  • 9. Population analysis of the pharmacokinetics and pharmacodynamics of RWJ-270201 (BCX-1812) in treating experimental influenza A and B virus in healthy volunteers.
    Iyer GR, Liao S, Massarella J.
    AAPS PharmSci; 2002 Feb; 4(4):E22. PubMed ID: 12645994
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs.
    Hurt AC, McKimm-Breschkin JL, McDonald M, Barr IG, Komadina N, Hampson AW.
    Virus Res; 2004 Jul; 103(1-2):205-11. PubMed ID: 15163511
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
    Hurt AC, Barr IG, Durrant CJ, Shaw RP, Sjogren HM, Hampson AW.
    Commun Dis Intell Q Rep; 2003 Jul; 27(4):542-7. PubMed ID: 15508516
    [Abstract] [Full Text] [Related]

  • 16. Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.
    McSharry JJ, McDonough AC, Olson BA, Drusano GL.
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):21-8. PubMed ID: 14715540
    [Abstract] [Full Text] [Related]

  • 17. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013-2014 season.
    Ikematsu H, Kawai N, Iwaki N, Kashiwagi S.
    J Infect Chemother; 2015 Sep; 21(9):634-8. PubMed ID: 26096495
    [Abstract] [Full Text] [Related]

  • 18. Anti-influenza virus activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its derivatives.
    Selvam P, Murugesh N, Chandramohan M, Sidwell RW, Wandersee MK, Smee DF.
    Antivir Chem Chemother; 2006 Sep; 17(5):269-74. PubMed ID: 17176631
    [Abstract] [Full Text] [Related]

  • 19. In vitro evaluation of the antiviral activity of methylglyoxal against influenza B virus infection.
    Charyasriwong S, Haruyama T, Kobayashi N.
    Drug Discov Ther; 2016 Sep; 10(4):201-10. PubMed ID: 27558282
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.